General Information of the Compound
Compound ID
CP0420715
Compound Name
7-(2-Hydroxy-ethyl)-1,3-dimethyl-3,7-dihydro-purine-2,6-dione
    Show/Hide
Synonyms
BETA-HYDROXYETHYL THEOPHYLLINE
Etofylline
    Show/Hide
Structure
Formula
C9H12N4O3
Molecular Weight
224.22
Canonical SMILES
Cn1c2ncn(CCO)c2c(=O)n(C)c1=O
    Show/Hide
InChI
InChI=1S/C9H12N4O3/c1-11-7-6(8(15)12(2)9(11)16)13(3-4-14)5-10-7/h5,14H,3-4H2,1-2H3
    Show/Hide
InChIKey
NWPRCRWQMGIBOT-UHFFFAOYSA-N
CAS
519-37-9
Physicochemical Property
logP
-1.574
Rotatable Bonds
2
Heavy Atom Count
16
Polar Areas
82.05
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
7
Complexity
16

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 1892
SID: 15043634
ChEMBL ID
CHEMBL699
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01278, Adenosine receptor A2b
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 17300 nM
   TI
   LI
   LO
   TS
Clinical Information about the Compound
Drug 1 ( BETA-HYDROXYETHYL THEOPHYLLINE )
Drug Name BETA-HYDROXYETHYL THEOPHYLLINE
Target(s)
Adenosine A2b receptor (ADORA2B)
Inhibitor